On Wednesday, December 18, 2024, the Barbara Ann Karmanos Cancer Institute announced being the first institute in the world to prescribe a new special kind of treatment for advanced liver cancer at home using electromagnetic waves – a device known as the “TheraBionic P1.”
Co-inventor Dr. Boris Pasche explained that the device has the ability to treat a patient’s primary tumor and spreading of cancer throughout their body. The electromagnetic treatment, which two Karmanos patients have already been prescribed, is intended to block tumor growth without affecting healthy tissue, according to a news release.
U CAN-CER VIVE is proud to be a nonprofit here in Michigan that devotes 100% of profits raised to help support vital cancer research here in Michigan. When doctors and researchers from Karmanos came to U CAN-CER VIVE to share this groundbreaking information, asking for support with funding the progression of this research, our board and committee members felt compelled to help! With financial support from our foundation, we look forward to watching this research thrive. It will allow for many additional Michigan Cancer patients to find success in their treatment plans.
“All of us at U CAN-CER VIVE were deeply inspired by the incredible advancements at the Karmanos Cancer Institute, like the TheraBionic P1 device. Innovations like this give hope to patients and families facing the most challenging diagnoses, offering not just treatment but precious time together. We are proud to support initiatives that push the boundaries of cancer care and improve lives across our community.” – Kelley LaFontaine, Co-Founder, U CAN-CER VIVE. Click below to read more!
